Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.53 |
| ▸ | EHMT1 | Q9H9B1 | 1/20 | 0.53 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.40 |
| ▸ | MAPT | P10636 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 3/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.36 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 5/20 | 0.36 |
| ▸ | RAB9A | P51151 | 5/20 | 0.36 |
| ▸ | HPGD | P15428 | 4/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11833495 | 0.83 | EHMT2 (0.70) | EHMT2EHMT1APOBEC3GALDH1A1KMT2A | |
| SCHEMBL1495026 | 0.83 | EHMT2 (0.53) | EHMT2EHMT1APOBEC3GALDH1A1KMT2A | |
| SCHEMBL14115866 | 0.83 | EHMT2 (0.53) | EHMT2EHMT1APOBEC3GALDH1A1KMT2A | |
| SCHEMBL5580505 | 0.82 | ALDH1A1 (0.57) | EHMT2EHMT1APOBEC3GALDH1A1KMT2A | |
| SCHEMBL11822538 | 0.80 | EHMT2 (0.64) | EHMT2EHMT1APOBEC3GALDH1A1KMT2A | |
| SCHEMBL14524400 | 0.80 | EHMT2 (0.64) | EHMT2EHMT1APOBEC3GALDH1A1KMT2A | |
| SCHEMBL11830911 | 0.80 | EHMT2 (0.64) | EHMT2EHMT1APOBEC3GALDH1A1KMT2A | |
| SCHEMBL17610651 | 0.79 | EHMT2 (0.48) | EHMT2EHMT1APOBEC3GALDH1A1KMT2A | |
| SCHEMBL5053893 | 0.79 | EHMT2 (0.48) | EHMT2EHMT1APOBEC3GALDH1A1KMT2A | |
| SCHEMBL15667399 | 0.79 | EHMT2 (0.48) | EHMT2EHMT1APOBEC3GALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 307 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2478049-B1 | A POLYMER SUPPORT | UNIV CAPE TOWN (ZA) | 2015-02-25 | — | — | EP | claimed |
| CN-101421323-B | Loaded latex optical molecular imaging probes | CARESTREAM HEALTH INC | 2013-03-13 | — | — | CN | claimed |
| CN-101421323-A | Loaded latex optical molecular imaging probes | CARESTREAM HEALTH INC (US) | 2009-04-29 | — | — | CN | claimed |
| EP-1605979-B1 | CONJUGATES FOR MEDICAL IMAGING COMPRISING CARRIER, TARGETING MOIETY AND A CONTRAST AGENT | UPPERTON LTD (GB) | 2008-10-22 | — | — | EP | claimed |
| WO-2006109311-A2 | ENZYME-CHANNELING BASED ELECTROCHEMICAL BIOSENSORS | RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) | 2006-10-19 | — | — | WO | claimed |
| WO-2024145445-A1 | METHODS OF CAPTURING TARGET ANALYTES | 10X GENOMICS, INC. (US) | 2024-07-04 | — | — | WO | disclosed |
| WO-2024138016-A1 | METHODS AND MATERIALS FOR PERFORMING ELECTROCHEMICAL ASSAYS | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 2024-06-27 | — | — | WO | disclosed |
| CN-118217402-A | Combination therapy for C3 inhibition | 阿佩利斯制药有限公司 | 2024-06-21 | — | — | CN | disclosed |
| CN-118103709-A | Space coding for suspension mass spectrometry flow cytometry | 标准生物工具加拿大公司 | 2024-05-28 | — | — | CN | disclosed |
| WO-2024081739-A2 | COVALENT COMPOUNDS AND USES THEREOF | THE GENERAL HOSPITAL CORPORATION (US) | 2024-04-18 | — | — | WO | disclosed |
| US-20240115655-A1 | DOSING REGIMENS AND RELATED COMPOSITIONS AND METHODS | SIXTH STREET LENDING PARTNERS | 2024-04-11 | — | — | US | disclosed |
| EP-4349363-A2 | DOSING REGIMENS | Apellis Pharmaceuticals, Inc. (US) | 2024-04-10 | — | — | EP | disclosed |
| US-4529712-A | Amino reactive end of a heterobifunctional crosslinking reagent connects to thiol reactive compound | RESEARCH CORPORATION (US) | 1985-07-16 | — | — | US | disclosed |
| EP-0146050-A2 | Site selective plasminogen activator and method of making and using same | Callewaert, Denis M. (US) | 1985-06-26 | — | — | EP | disclosed |
| EP-0124221-A1 | Method of detecting a polynucleotide sequence and labelled polynucleotides useful therein | Malcolm, Alan David Blair (GB) | 1984-11-07 | — | — | EP | disclosed |
| WO-1984003520-A1 | METHOD OF DETECTING A POLYNUCLEOTIDE SEQUENCE AND LABELLED POLYNUCLEOTIDES USEFUL THEREIN | BLAIR MALCOLM A D | 1984-09-13 | — | — | WO | disclosed |
| EP-0112720-A2 | Conjugate having cytotoxicity and process for the preparation thereof | TEIJIN LIMITED (JP) | 1984-07-04 | — | — | EP | disclosed |
| US-4429008-A | AGGLUTINATION ASSAYS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1984-01-31 | — | — | US | disclosed |
| EP-0097691-A1 | THIOL REACTIVE LIPOSOMES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1984-01-11 | — | — | EP | disclosed |
| WO-1983002069-A1 | THIOL REACTIVE LIPOSOMES | UNIV CALIFORNIA (US) | 1983-06-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240115655-A1 | DOSING REGIMENS AND RELATED COMPOSITIONS AND METHODS | C1QBP, C3AR1, C9 | EHMT2 4611/4885EHMT1 4378/4885APOBEC3G 396/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.